FCE 28654 is used as an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor to lower blood cholesterol levels and modify hepatic cholesterol profiles by increasing the free/esterified cholesterol ratio in hypercholesterolemic rats; it also reduces microsomal ACAT activity in rat plasma.